BioLargo, Inc. (OTCQB: BLGO) manufactures technology-based products that help solve global issues that threaten water, food, agriculture, healthcare and energy. The company’s Advanced Oxidation Systems includes its AOS Filter, designed to eliminate toxic contaminants in water in a fraction of the time and cost of current technologies. BioLargo also owns a 50% interest in the Isan System and operates three subsidiaries:  BioLargo Water; Odor-No-More, serving the pet, equine, and consumer markets; and Clyra Medical Technologies, focused on advanced wound care management and preparing to make FDA 510(k) applications in 2014. For more information, visit the company’s website at www.biolargo.com